Retatrutide is a triple hormone receptor agonist, engineered to activate GLP-1, GIP, and glucagon receptors simultaneously. This tri-agonist mechanism has made it a focus of active interest in metabolic and endocrine research, allowing investigators to study coordinated multi-receptor signaling on glucose regulation, appetite pathways, and systemic energy balance beyond what single- or dual-agonist compounds allow. Supplied as a sterile, lyophilized powder, it is intended strictly for laboratory research applications.
Retatrutide
Lyophilized Powder, ≥99% Purity
$80.00 – $230.00Price range: $80.00 through $230.00
Retatrutide is a triple-receptor (GLP-1/GIP/glucagon) research peptide studied for its role in metabolic signaling, energy expenditure, and appetite-pathway research.
Additional information
| Size | 5MG, 10MG, 20MG |
|---|
Researchers use this compound to examine how simultaneous GLP-1/GIP/glucagon receptor activation influences hepatic lipid metabolism, lipolysis, and cellular energy expenditure in preclinical models. Its extended pharmacokinetic profile supports longer observation windows in comparative incretin-receptor studies. Reconstitute with bacteriostatic water and store at 2°C–8°C; use precise peptide-math calculations to maintain consistent molarity across batches.
Store between 2°C and 8°C. Protect from light. Reconstitute only the amount needed.
Retatrutide is supplied strictly for laboratory research use only. It is not intended for human or animal consumption, medical treatment, or diagnostic purposes. All handling and use must comply with applicable laboratory regulations and research standards.
For laboratory research use only. Not for human or veterinary consumption.
Related products
Semaglutide
Lyophilized Powder, ≥99% Purity
MOTS-c
Lyophilized Powder, ≥99% Purity
SLU-PP-332
Lyophilized Powder, ≥99% Purity
Tirzepatide
Lyophilized Powder, ≥99% Purity

